Coleman Mark bought AXSM
September 8, 2025 · Form 4 insider transaction
Coleman Mark bought 800 shares of Axsome Therapeutics, Inc. at $127.20 per share, a transaction worth $101.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
800
Price
$127.20
Total value
$101.8K
InsiderColeman Mark
RoleDirector
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 8, 2025
Filing dateSeptember 9, 2025
Shares owned after47,437
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the open market purchase of shares of the Issuer's common stock.